BioMarin Pharmaceutical (BMRN) hikes on Shire interest

Loading...
Loading...
BioMarin Pharmaceutical Inc.
BMRN
gained 14.3% to $132.08 on rumour of Shire interest. Deutsche Bank lifted the price target on the stock from $90 to $140. Share volume was four million, compared to an all-day average of 1.4 million
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!

Loading...